First-Time-in-Human & First In Man Studies
Based within the safe environment of two of the largest NHS teaching hospitals and with the highest clinical research standards certified by the MHRA standard and supplementary accreditation, Richmond Pharmacology is ideally suited to run intricate First time into Human studies. Richmond Pharmacology’s extensive experience covers a wide range of therapeutic areas and research methodologies.
Richmond Pharmacology conduct a wide range of First in Human studies, including those that require submission to the Expert Advisory Group (EAG), and the "under one roof" approach ensures Richmond Pharmacology can deal with all aspects of these trials from protocol writing through to the production of a final report.
Our location within two acute NHS hospitals and our partnership agreements with these hospitals ensures we have direct on-site integration with regard to emergency support and facilities including the hospitals.':
All clinical staff at Richmond Pharmacology are mandated to regularly attend life support training.
The primary objective is to conduct research. The wards at Richmond Pharmacology are designed to ensure volunteer safety. They are designed to guarantee that all volunteers can be observed at all times from a central nurses' station. Call buttons ensure the necessary staff can be alerted to an urgent situation rapidly. The design of the wards allows for easy access in and out to deal with all urgent situations efficiently.
Richmond Pharmacology’s in house data management team routinely provide data for interim analysis and dose escalation conferences within very short timelines.
All studies conducted by Richmond Pharmacology are closely supervised by one of two senior medical doctors who act as principle investigators for all clinical trials conducted at Richmond Pharmacology. This provision of medical cover far exceeds current industry requirements as listed in the 2001 ABPI guidelines.